Home › Funds › Vivo Capital, LLC › ATOS

Vivo Capital, LLC position in ATOS

Attovia Therapeutics Inc · Health Care

Vivo Capital, LLC reported holding 300,000 shares of ATOS (Attovia Therapeutics Inc) in its Q3 2026 13F filing — a position valued at US$5.1M, representing 0.58% of its reported portfolio and ranking #37 among its reported holdings. Vivo Capital, LLC first reported this position in Q3 2026.

Latest position (Q3 2026)300.00K sh
Reported value held$5.14M
Portfolio Weight0.58%
First reportedQ3 2026
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vivo Capital, LLC's ATOS position evolved

Vivo Capital, LLC first disclosed a stake in ATOS in Q3 2026 at 300,000 shares (US$5.1M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 300.00K $5.14M New

About ATOS and 13F data

ATOS (Attovia Therapeutics Inc) is a Health Care company. 24 other funds we track also report a position in ATOS — the largest reported positions include Sanofi (US$18.6M), Kalehua Capital Management LLC (US$3.4M), Jones Hill Capital LP (US$3.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ATOS

All ATOS fund holders →

FAQ

How long has Vivo Capital, LLC held ATOS?

Vivo Capital, LLC has disclosed ATOS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Vivo Capital, LLC's current position in ATOS?

As of Q3 2026, Vivo Capital, LLC holds 300.00K shares of ATOS (Attovia Therapeutics Inc), valued at $5.14M, representing 0.58% of its reported portfolio and ranking #37.

Has Vivo Capital, LLC been buying or selling ATOS?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC newly opened its position in ATOS.

Which other funds hold ATOS?

Other major institutional holders of ATOS include Sanofi, Kalehua Capital Management LLC, Jones Hill Capital LP, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.